Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cross

Showing results (501-510 of 595) with videos related to

Pageof 60
Sort By:
Leukemia|November 7, 2008
The molecular anatomy of the FIP1L1-PDGFRA fusion geneC Walz, J Score, J Mix, et al.
Blood|September 17, 2011
EZH2 mutational status predicts poor survival in myelofibrosisPaola Guglielmelli, Flavia Biamonte, Joannah Score, et al.
Blood|April 24, 2009
Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasmsFrancis H Grand, Claire E Hidalgo-Curtis, Thomas Ernst, et al.
Blood|August 8, 2008
Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trialsSusan Branford, Linda Fletcher, Nicholas C P Cross, et al.
Annals of Hematology|November 28, 2013
The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosisPhilipp Erben, Juliana Schwaab, Georgia Metzgeroth, et al.
Leukemia|October 22, 2010
IDH2 somatic mutations in chronic myeloid leukemia patients in blast crisisS Soverini, J Score, I Iacobucci, et al.
Leukemia|July 29, 2017
Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophiliaM Jawhar, N Naumann, M Knut, et al.
Leukemia|July 11, 2006
Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myelomaL Chiecchio, R K M Protheroe, A H Ibrahim, et al.
Plos One|February 14, 2012
TET2 mutations are associated with specific 5-methylcytosine and 5-hydroxymethylcytosine profiles in patients with chronic myelomonocytic leukemiaCristina Pérez, Nicolas Martínez-Calle, José Ignacio Martín-Subero, et al.
Leukemia|May 23, 2024
Recommendations from the AML molecular MRD expert advisory boardStuart Scott, Alison Devonshire, Richard Dillon, et al.
Pageof 60

Showing results (501-510 of 595) with videos related to

Sort By:
Pageof 60
Leukemia|November 7, 2008
The molecular anatomy of the FIP1L1-PDGFRA fusion geneC Walz, J Score, J Mix, et al.
Blood|September 17, 2011
EZH2 mutational status predicts poor survival in myelofibrosisPaola Guglielmelli, Flavia Biamonte, Joannah Score, et al.
Blood|April 24, 2009
Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasmsFrancis H Grand, Claire E Hidalgo-Curtis, Thomas Ernst, et al.
Blood|August 8, 2008
Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trialsSusan Branford, Linda Fletcher, Nicholas C P Cross, et al.
Annals of Hematology|November 28, 2013
The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosisPhilipp Erben, Juliana Schwaab, Georgia Metzgeroth, et al.
Leukemia|October 22, 2010
IDH2 somatic mutations in chronic myeloid leukemia patients in blast crisisS Soverini, J Score, I Iacobucci, et al.
Leukemia|July 29, 2017
Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophiliaM Jawhar, N Naumann, M Knut, et al.
Leukemia|July 11, 2006
Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myelomaL Chiecchio, R K M Protheroe, A H Ibrahim, et al.
Plos One|February 14, 2012
TET2 mutations are associated with specific 5-methylcytosine and 5-hydroxymethylcytosine profiles in patients with chronic myelomonocytic leukemiaCristina Pérez, Nicolas Martínez-Calle, José Ignacio Martín-Subero, et al.
Leukemia|May 23, 2024
Recommendations from the AML molecular MRD expert advisory boardStuart Scott, Alison Devonshire, Richard Dillon, et al.
Pageof 60